Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Fukami

Showing results (21-30 of 177) with videos related to

Pageof 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2016
Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and DogTakaya Kurokawa, Tatsuki Fukami, Tomohiro Yoshida, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2026
N<sup>6</sup>-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cellsTakuto Inamoto, Masataka Nakano, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2011
Human paraoxonase 1 is the enzyme responsible for pilocarpine hydrolysisTomomi Hioki, Tatsuki Fukami, Miki Nakajima, et al.
Biochemical Pharmacology|July 21, 2018
In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injuryKeigo Konishi, Tatsuki Fukami, Takuo Ogiso, et al.
Drug Metabolism and Pharmacokinetics|March 12, 2015
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug developmentShingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity DrugKeiya Hirosawa, Tatsuki Fukami, Masataka Nakano, et al.
Drug Metabolism and Pharmacokinetics|April 19, 2021
Identification of miRNAs that regulate human CYP2B6 expressionMasataka Nakano, Chika Iwakami, Tatsuki Fukami, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 15, 2019
Strain and sex differences in drug hydrolase activities in rodent liversFumiya Kisui, Tatsuki Fukami, Masataka Nakano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2013
Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidneyShingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2014
Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylaseMai Shimizu, Tatsuki Fukami, Miki Nakajima, et al.
Pageof 18

Showing results (21-30 of 177) with videos related to

Sort By:
Pageof 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 2016
Arylacetamide Deacetylase is Responsible for Activation of Prasugrel in Human and DogTakaya Kurokawa, Tatsuki Fukami, Tomohiro Yoshida, et al.
Drug Metabolism and Pharmacokinetics|April 8, 2026
N<sup>6</sup>-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cellsTakuto Inamoto, Masataka Nakano, Tatsuki Fukami, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 28, 2011
Human paraoxonase 1 is the enzyme responsible for pilocarpine hydrolysisTomomi Hioki, Tatsuki Fukami, Miki Nakajima, et al.
Biochemical Pharmacology|July 21, 2018
In vitro approach to elucidate the relevance of carboxylesterase 2 and N-acetyltransferase 2 to flupirtine-induced liver injuryKeigo Konishi, Tatsuki Fukami, Takuo Ogiso, et al.
Drug Metabolism and Pharmacokinetics|March 12, 2015
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug developmentShingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 3, 2023
Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity DrugKeiya Hirosawa, Tatsuki Fukami, Masataka Nakano, et al.
Drug Metabolism and Pharmacokinetics|April 19, 2021
Identification of miRNAs that regulate human CYP2B6 expressionMasataka Nakano, Chika Iwakami, Tatsuki Fukami, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 15, 2019
Strain and sex differences in drug hydrolase activities in rodent liversFumiya Kisui, Tatsuki Fukami, Masataka Nakano, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 13, 2013
Epigenetic regulation is a crucial factor in the repression of UGT1A1 expression in the human kidneyShingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2014
Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylaseMai Shimizu, Tatsuki Fukami, Miki Nakajima, et al.
Pageof 18